novo nordisk glp 1 drug GLP-1 Fails to Quell Alzheimer's in Trials Novo Nordisk GLP-1 Drug Meets

They belong to completely different drug classes, work through different mechanisms, and have different effects on weight, appetite, and cardiovascular health

Zhou et al., 2018)

M., Puddicombe, S

References Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW et al (2018) IDF Diabetes Atlas: global estimates of diabetes prevalence for 2017 and projections for 2045

AI in Antiobesity Drug Discovery The application of machine learning (ML) and AI in drug discovery is accelerating the identification of novel targets and candidate compounds for obesity treatment [81]

They're eating just enough to maintain their normal body fat